Prevalence use of nonsteroidal anti-inflammatory drugs in the general population with COVID-19 and associated COVID-19 risk, hospitalization, severity, death, and safety outcomes: A systematic review and meta-analysis

Huilei Zhao, Shanshan Huang, Kaibo Mei, Wen Shao, Jing Zhang, Jianyong Ma, Wengen Zhu, Yuan Jiang, Peng Yu, Xiao Liu
doi: https://doi.org/10.1101/2021.05.01.21256428

Article usage

Article usage: May 2021 to January 2025

AbstractFullPdf
May 202170325112
Jun 2021122735
Jul 202179826
Aug 2021118917
Sep 202161715
Oct 2021781123
Nov 202168927
Dec 202148815
Jan 2022241211
Feb 20222605
Mar 20222226
Apr 20223625
May 202233014
Jun 202228067
Jul 202219056
Aug 20222836
Sep 202242111
Oct 20223225
Nov 20221905
Dec 20221936
Jan 20231907
Feb 20232223
Mar 20231300
Apr 202319116
May 20231027
Jun 2023757
Jul 2023815
Aug 202316105
Sep 20231446
Oct 20231201
Nov 202316513
Dec 20232603
Jan 20247213
Feb 20242255
Mar 20248064
Apr 20242334
May 2024826
Jun 20241235
Jul 20241358
Aug 20241337
Sep 20241726
Oct 202410714
Nov 20241025
Dec 20241719
Jan 2025300
Back to top
Posted May 05, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Prevalence use of nonsteroidal anti-inflammatory drugs in the general population with COVID-19 and associated COVID-19 risk, hospitalization, severity, death, and safety outcomes: A systematic review and meta-analysis
Huilei Zhao, Shanshan Huang, Kaibo Mei, Wen Shao, Jing Zhang, Jianyong Ma, Wengen Zhu, Yuan Jiang, Peng Yu, Xiao Liu
medRxiv 2021.05.01.21256428; doi: https://doi.org/10.1101/2021.05.01.21256428
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area